Back
Direxion Daily S&P 500® Hi Bt Bl 3X ETF Vs. ProShares Ultra Nasdaq Biotechnology Industry Stock Comparison
Buy
77
HIBL
Direxion Daily S&P 500® Hi Bt Bl 3X ETF
Last Price:
40.39
Seasonality Move:
17.81%
Buy
61
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
55.53
Seasonality Move:
12.47%
Buy
77
Direxion Daily S&P 500® Hi Bt Bl 3X ETF (HIBL)
is a Buy
Is Direxion Daily S&P 500® Hi Bt Bl 3X ETF a Buy, Sell or Hold?
- The current Direxion Daily S&P 500® Hi Bt Bl 3X ETF [HIBL] share price is $40.43. The Score for HIBL is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- HIBL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Buy
Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?
- The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $54.96. The Score for BIB is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- BIB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HIBL Stock Price Chart
What is Direxion Daily S&P 500® Hi Bt Bl 3X ETF's stock price today?
-
The Direxion Daily S&P 500® Hi Bt Bl 3X ETF share price today is $40.43
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HIBL is experiencing buying pressure, which is a positive indicator for future bullish movement.
BIB Stock Price Chart
What is ProShares Ultra Nasdaq Biotechnology's stock price today?
-
The ProShares Ultra Nasdaq Biotechnology share price today is $54.96
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIB is experiencing slight selling pressure.
HIBL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.74 | Sell |
| Relative Strength Index (14 RSI): | 48.39 | Sell |
| Chaikin Money Flow: | 39552 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.88 - 43.46) | Sell |
| Bollinger Bands (100): | (38.91 - 44.83) | Sell |
BIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.26 | Buy |
| Relative Strength Index (14 RSI): | 57.7 | Buy |
| Chaikin Money Flow: | -4538 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.4 - 54.26) | Buy |
| Bollinger Bands (100): | (52.78 - 59.24) | Sell |
HIBL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.99 | Buy |
| 20-day SMA: | 39.58 | Buy |
| 50-day SMA: | 43.02 | Sell |
| 200-day SMA: | 36.25 | Buy |
| 8-day EMA: | 40.15 | Buy |
| 20-day EMA: | 40.54 | Sell |
| 50-day EMA: | 41.45 | Sell |
| 200-day EMA: | 37.94 | Buy |
BIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.72 | Buy |
| 20-day SMA: | 51.39 | Buy |
| 50-day SMA: | 54.55 | Buy |
| 200-day SMA: | 52.03 | Buy |
| 8-day EMA: | 53.9 | Buy |
| 20-day EMA: | 52.88 | Buy |
| 50-day EMA: | 53.75 | Buy |
| 200-day EMA: | 53.58 | Buy |
Direxion Daily S&P 500® Hi Bt Bl 3X ETF Earnings Growth & HIBL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Direxion Daily S&P 500® Hi Bt Bl 3X ETF Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||